Related Experiment Video
Updated: Feb 12, 2026

Three-Dimensional Printing of a Complex Aortic Anomaly
Published on: November 1, 2018
High-Sensitivity C-Reactive Protein and Risk of Recurrent Vascular Events in Patients With Stroke Associated With
Takao Hoshino1, Kentaro Ishizuka1, Takafumi Mizuno1
1Department of Neurology, Tokyo Women's Medical University Hospital Tokyo Japan.
Insights
High-sensitivity C-reactive protein (hsCRP) elevation predicts major adverse cardiovascular events (MACE) in patients with complex aortic atheroma (CAA) stroke. This finding aids risk stratification for recurrent vascular events in this high-risk group.
Area of Science:
- Cardiology
- Neurology
- Vascular Medicine
Background:
- Complex aortic atheroma (CAA) is a significant risk factor for ischemic stroke.
- Predictors of recurrent vascular events in CAA-related stroke are not well-defined.
- Systemic inflammation may play a role in stroke recurrence.
Purpose of the Study:
- To evaluate the prognostic value of high-sensitivity C-reactive protein (hsCRP) in patients with CAA-related stroke.
- To determine if hsCRP levels can predict major adverse cardiovascular events (MACE).
- To assess the association between hsCRP and recurrent vascular events.
Main Methods:
- Prospective, observational registry of consecutive stroke patients within 1 week of onset.
- Transesophageal echocardiography (TEE) used for embolic-source evaluation and CAA definition (plaque ≥4 mm, ulceration, or mobile components).
- Patients dichotomized by hsCRP level (≥3.0 mg/L vs. <3.0 mg/L); primary outcome was 1-year MACE.
Main Results:
- Out of 1,214 patients, 335 underwent TEE, identifying CAA in 83 (24.8%).
- Among 76 patients with hsCRP data and 1-year follow-up, 17 experienced MACE (23.2% event rate).
- MACE incidence was significantly higher in patients with hsCRP ≥3.0 mg/L (42.2%) compared to hsCRP <3.0 mg/L (15.3%; P=0.010).
- Elevated hsCRP (≥3.0 mg/L) independently predicted MACE (HR 4.68; 95% CI 1.43-15.32).
Conclusions:
- Elevated hsCRP is an independent predictor of MACE in CAA-related stroke.
- hsCRP can aid in risk stratification for patients with CAA and stroke.
- These findings highlight the role of systemic inflammation in the vascular events of this high-risk subgroup.
Background:
Complex aortic atheroma (CAA) is a high-risk source of ischemic stroke, yet predictors of recurrent vascular events in CAA-related stroke remain poorly defined. We evaluated the prognostic value of high-sensitivity C-reactive protein (hsCRP).
Methods And Results:
This single-center, prospective, observational registry enrolled consecutive patients with stroke within 1 week of onset. Transesophageal echocardiography (TEE) was not protocol-mandated but used at physician discretion, mainly for embolic-source evaluation. CAA was defined as any plaque ≥4 mm in thickness or a plaque with ulceration or mobile components on TEE. Patients were dichotomized by hsCRP at 3.0 mg/L. The primary outcome was 1-year major adverse cardiovascular events (MACE), including stroke, acute coronary syndrome, and vascular death. Among 1,214 patients, TEE was performed in 335; CAA was identified in 83 (24.8%). Seventy-six with hsCRP data were analyzed, with 1-year follow up obtained in 73 (96.1%). Over 1 year, 17 patients had at least 1 vascular event, yielding an event rate of 23.2%. The incidence of MACE was significantly higher in patients with hsCRP ≥3.0 mg/L than in those with hsCRP <3.0 mg/L (42.2% vs. 15.3%; log-rank P=0.010). In multivariable Cox analysis, hsCRP ≥3.0 mg/L independently predicted MACE (hazard ratio 4.68; 95% confidence interval 1.43-15.32).
Conclusions:
Elevated hsCRP is independently associated with an increased risk of MACE in CAA-related stroke. hsCRP may aid risk stratification and underscores the role of systemic inflammation in this high-risk subgroup.
More Related Videos
Related Concept Videos
Protein Complex Assembly
Many viruses self-assemble into a fully functional unit using the infected host cell to...
Protein Complex Assembly
Protein Complexes with Interchangeable Parts
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
Protein Complexes with Interchangeable Parts
Relative Risk
Seedless Vascular Plants

